In a BIMBO operation, the EMKA Group founding-managing director, the SCIREQ Canadian subsidiary and BNP Paribas Developpement acquired Siparex minority stake.
Created by Jean-Gérard Napoléoni in 1992, the EMKA Technologies Group is a world leader in the design, manufacture and distribution of systems for preclinical cardiology, neurological and pulmonary research.
With an international team of 80 people, the Group, which generates close to € 10M sales, offers a comprehensive range of products, software and services for preclinical researchers (pharmaceutical companies, CROs and universities) through 5 entities in France, Canada, USA, China and Japan.
Since the acquisition in 2014 of SCIREQ, a Canadian company led by David Brunet, the group has been able to accelerate its development, particularly in the pulmonary segment.
This BIMBO operation sets a new stage in the development of the Group. It allows Siparex to sell its minority stake in favor of BNP Paribas Developpement and David Brunet. The founding-managing director Jean-Gérard Napoléoni remains majority shareholder.
Over 90 delegates from IMAP member firms representing 32 countries congregated in Miami on October 25th - 27th for IMAP’s 2018 Fall conference. The conference was hosted by Falls River Group, IMAP’s partner firm in Florida, and was set around the theme of ‘Disruptive Innovation’.